Viewing nowCombinationRiseone Plus Tablet
Risedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201605323 · Approved 2016.08.31 · Insurance code 671806270
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This medication is used to treat and prevent osteoporosis in postmenopausal women. It is also effective in treating osteoporosis in men. Specifically, it helps increase bone density and reduce the risk of fractures, thereby improving bone health. It plays a beneficial role in reducing complications related to osteoporosis and in maintaining healthy bones. It is used for those with osteoporosis to enhance bone strength and maintain bone structure.
Adults: Take 1 tablet of this medication orally once a week. Elderly patients: In elderly patients (60 years and older), the bioavailability and pharmacokinetics of this medication are similar to those in younger people, so no dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This medication is contraindicated in patients with severe renal impairment with a creatinine clearance below 30ml/min. Food interferes with the absorption of this medication. To ensure adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To help this medication reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with an adequate amount of plain water (170 ~ 230ml). Taking this medication with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medication because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this medication. Patients with inadequate dietary intake of calcium and vitamin D should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplementation, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medication once weekly provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take this medication on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Pediatric patients: The safety and efficacy in children and growing adolescents have not been established.
This drug may irritate the gastrointestinal mucosa, leading to risks of esophageal diseases such as esophagitis or esophageal ulcers. Take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. If symptoms such as difficulty swallowing, pain behind the breastbone, or heartburn occur, discontinue use immediately and consult a physician. This drug should not be administered to patients with delayed esophageal transit, hypocalcemia, or severe renal impairment. Additionally, patients with lactose intolerance or specific inherited metabolic disorders should not take this drug. While taking this medication, gastrointestinal symptoms such as nausea, diarrhea, or abdominal pain may occur, and in rare cases, serious gastrointestinal conditions such as gastric ulcers or duodenitis may develop. Reports of bone pain, joint pain, and muscle pain have been noted, and skin rashes or itching may also occur. Consult a dental specialist regarding the risk of jaw necrosis if dental treatment is needed. Also, if there is pain or discharge from the ear while taking this medication, consider the possibility of external auditory canal necrosis. It is advisable not to take this medication in conjunction with drugs or foods containing divalent cations such as calcium, magnesium, or iron, and to avoid eating for a certain time before and after taking it. Use of this medication during pregnancy or breastfeeding should be approached with caution, and it is recommended to discontinue use or stop breastfeeding during treatment. Safety for children has not been established, and no special precautions are needed for the elderly. In case of overdose, serum calcium and phosphorus levels may decrease, which can lead to symptoms of hypocalcemia; thus, calcium supplementation and gastric lavage may be necessary if required. Keep this medication out of reach of children, and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture ingress and keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the efficacy of the medication over time.
Pale orange oval coated tablets
4 tablets (4 tablets/PTPx1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Yu Young Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 40.162mg · Cholecalciferol Concentrate Powder 56mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.